Skip to menu Skip to content Skip to footer

2010

Conference Publication

Evaluation of limited sampling strategies for estimation of mycophenolic acid exposure following mycophenolate mofetil intake in adult kidney transplant recipients

Barraclough, K. A., Campbell, S. B., Franklin, M. E., Isbel, N. M., Johnson, D. W., Lee, K. J., Petchey, W.G., Staatz, C. E. and Taylor, P. J. (2010). Evaluation of limited sampling strategies for estimation of mycophenolic acid exposure following mycophenolate mofetil intake in adult kidney transplant recipients. XXIII International Congress of the Transplant Society, Vancouver Canada, 15-19 August 2010.

Evaluation of limited sampling strategies for estimation of mycophenolic acid exposure following mycophenolate mofetil intake in adult kidney transplant recipients

2010

Conference Publication

Effects of emeprazole versus ranitidine on mycophenolic acid pharmacokinetics in adult kidney transplant recipients

Barraclough, Katherine, Fan, Petrina, Isbel, Nicole, Lee, Katie, Johnson, David, Campbell, Scott, Leary, Diana and Staatz, Christine (2010). Effects of emeprazole versus ranitidine on mycophenolic acid pharmacokinetics in adult kidney transplant recipients. TSANZ Annual Scientific Meeting, Canberra, 23-25 June 2010. Australia: Nature Publishing Group.

Effects of emeprazole versus ranitidine on mycophenolic acid pharmacokinetics in adult kidney transplant recipients

2010

Conference Publication

Evaluation of limited sampling strategies for tacrolimus (Prograf®) exposure in adult kidney transplant recipients

Barraclough, K. A., Isbel, N. M., Johnson, D. W., Campbell, S. B., Leary, D. R., Lee, K. L., Staatz, C. E. and Taylor, P. J. (2010). Evaluation of limited sampling strategies for tacrolimus (Prograf®) exposure in adult kidney transplant recipients. XXIII International Congress of the Transplant Society, Vancouver, Canada, 15-19 August 2010.

Evaluation of limited sampling strategies for tacrolimus (Prograf®) exposure in adult kidney transplant recipients

2010

Conference Publication

Prednisolone pharmacokinetics and sparse sampling strategies for monitoring in adult renal transplant recipients

Barraclough, K. A., Isbel, N. M., Johnson, D. W., Medley, G., Leary, D. R., Campbell, S. B. and Staatz, C. E. (2010). Prednisolone pharmacokinetics and sparse sampling strategies for monitoring in adult renal transplant recipients. TSANZ Annual Scientific Meeting, Canberra, 23-25 June 2010. Australia: Nature Publishing Group.

Prednisolone pharmacokinetics and sparse sampling strategies for monitoring in adult renal transplant recipients

2010

Conference Publication

Prednisolone pharmacokinetics and sparse sampling strategies for monitoring in adult renal transplant recipients

Barraclough, K. A., Campbell, S. B., Isbel, N. M., Johnson, D. W., Leary, D. R., Medley, G. and Staatz, C. E. (2010). Prednisolone pharmacokinetics and sparse sampling strategies for monitoring in adult renal transplant recipients. XXIII International Congress of the Transplant Society, Vancouver Canada, 15-19 August 2010.

Prednisolone pharmacokinetics and sparse sampling strategies for monitoring in adult renal transplant recipients

2009

Conference Publication

Oxidative stress markers in alternate nightly noctural haemodialysis

Van Eps, CL, Coombes, JS, Matsumoto, A, Jeffries, JK, Johnson, DW, Campbell, SB, Isbel, NM, Mudge, DW and Hawley, CM (2009). Oxidative stress markers in alternate nightly noctural haemodialysis. 45th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrolog, Hobart, Tasmania, Australia, 7–9 September 2009. Carlton, Vic., Australia: Blackwell Science. doi: 10.1111/j.1440-1797.2009.001176.x

Oxidative stress markers in alternate nightly noctural haemodialysis

2009

Conference Publication

NO IMPROVEMENT IN CARDIAC STRUCTURE AND FUNCTION IN ALTERNATE NIGHTLY HAEMODIALYSIS

Van Eps, CL, Jeffries, L, Haluska, B, Hawley, CM, Jeffries, J, Johnson, DW, Campbell, SB, Isbel, NM, Mudge, DW and Marwick, TH (2009). NO IMPROVEMENT IN CARDIAC STRUCTURE AND FUNCTION IN ALTERNATE NIGHTLY HAEMODIALYSIS. 45th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Hobart, Australia, 7–9 September 2009. MALDEN: WILEY-BLACKWELL PUBLISHING, INC.

NO IMPROVEMENT IN CARDIAC STRUCTURE AND FUNCTION IN ALTERNATE NIGHTLY HAEMODIALYSIS

2009

Conference Publication

The impact of aggressive risk factor modification in renal transplant recipients with impaired glucose tolerance or diabetes on the development of de novo cardiac events

Kaisar, M, Armstrong, K, Hawley, C, Pidcock, R, Johnson, D, Prins, JB, Marwick, T and Isbel, N (2009). The impact of aggressive risk factor modification in renal transplant recipients with impaired glucose tolerance or diabetes on the development of de novo cardiac events. 45th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Hobart, Australia, 7 - 9 September, 2009. Carlton, Australia: Wiley Interscience.

The impact of aggressive risk factor modification in renal transplant recipients with impaired glucose tolerance or diabetes on the development of de novo cardiac events

2009

Conference Publication

Body mass index is independently associated with inflammatory burden in patients with chronic kidney disease

Petchey, WG, Campbell, S, Van Eps, C, Mudge, D, Johnson, D, Hawley, C and Isbel, N (2009). Body mass index is independently associated with inflammatory burden in patients with chronic kidney disease. 45th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Hobart, Australia, 7 - 9 September, 2009. Carlton, Australia: Wiley InterScience. doi: 10.1111/j.1440-1797.2009.01176.x

Body mass index is independently associated with inflammatory burden in patients with chronic kidney disease

2008

Conference Publication

TWO CASES OF ADENOVIRUS INFECTION IN KIDNEY TRANSPLANT RECIPIENTS

Barraclough, K., Oliver, K., Playford, G., Preston, J., Campbell, S. and Isbel, N. (2008). TWO CASES OF ADENOVIRUS INFECTION IN KIDNEY TRANSPLANT RECIPIENTS. HOBOKEN: WILEY-BLACKWELL.

TWO CASES OF ADENOVIRUS INFECTION IN KIDNEY TRANSPLANT RECIPIENTS

2007

Conference Publication

Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients

Hourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Gandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. American Transplant Congress, San Francisco, CA, USA, 5-9 May 2007. Oxford, England: Wiley-Blackwell. doi: 10.1111/j.1600-6143.2007.01811.x

Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients

2007

Conference Publication

Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients

Hourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Ghandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients. American Transplant Congress 2007, USA, 5-9 May 2007. UK: Wiley-Blackwell Publising Ltd.. doi: 10.1111/j.1600-6143.2007.01811.x

Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients

2006

Conference Publication

Cardiorespiratory fitness is related to physical inactivity, metabolic syndrome and atherosclerotic burden in glucose-intolerant renal transplant recipients

Armstrong, K., Rakhit, D., Pidcock, R., Orazio, L., Prins, J., Jeffriess, L., Marwick, T., Johnson, D. and Isbel, N. (2006). Cardiorespiratory fitness is related to physical inactivity, metabolic syndrome and atherosclerotic burden in glucose-intolerant renal transplant recipients. 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand, The Australian Academy of Science, Canberra, ACT, Australia, 29–31 March 2006. Basingstoke, U.K.: Nature Publishing Group. doi: 10.1111/j.1440-1711.2006.01450.x

Cardiorespiratory fitness is related to physical inactivity, metabolic syndrome and atherosclerotic burden in glucose-intolerant renal transplant recipients

2006

Conference Publication

Subclinical left ventricular abnormalities predict outcome in chronic kidney disease and are reversible with renal transplantation

Rakhit, Dhrubo J., Zhang, X. H., Leano, R., Armstrong, K. A., Isbel, N. M. and Marwick, T. H. (2006). Subclinical left ventricular abnormalities predict outcome in chronic kidney disease and are reversible with renal transplantation. 55th Annual Scientific Session of the American-College-of-Cardiology, Atlanta, Georgia, 11th-14th March, 2006. New York: Elsevier Inc.. doi: 10.1016/j.jacc.2006.01.013

Subclinical left ventricular abnormalities predict outcome in chronic kidney disease and are reversible with renal transplantation

2006

Conference Publication

Reduced adiponectin is associated with an adverse cardiovascular risk factor profile in glucose-intolerant renal transplant recipients

Armstrong, K, Johnson, D, Marks, L, Isbel, N and Prins, J (2006). Reduced adiponectin is associated with an adverse cardiovascular risk factor profile in glucose-intolerant renal transplant recipients. XLIII ERA-EDTA Congress, Glasgow, United Kingdom, 15-18 July, 2006. Oxford: OXFORD UNIV PRESS.

Reduced adiponectin is associated with an adverse cardiovascular risk factor profile in glucose-intolerant renal transplant recipients

2006

Conference Publication

Use of dobutamine echocardiography for cardiovascular event prediction in chronic kidney disease: Clinical scoring algorithms can optimise patients selection for testing

Rakhit, DJ, Armstrong, KA, Johnson, DW, Isbel, NM and Marwick, TH (2006). Use of dobutamine echocardiography for cardiovascular event prediction in chronic kidney disease: Clinical scoring algorithms can optimise patients selection for testing. Annual Meeting of the British-Society-of-Echocardiography, Birmingham, England, 2005.

Use of dobutamine echocardiography for cardiovascular event prediction in chronic kidney disease: Clinical scoring algorithms can optimise patients selection for testing

2006

Conference Publication

Effectiveness of a cardiovascular risk factor modification program in insulin-resistant renal transplant recipients

Armstrong, K., Johnson, D., De Silva, N., Pidcock, R., Orazio, L., Prins, J., Campbell, S., Hawley, C., Mudge, D., Marwick, T. and Isbel, N. (2006). Effectiveness of a cardiovascular risk factor modification program in insulin-resistant renal transplant recipients. 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand, The Australian Academy of Science Canberra, ACT, Australia, 29–31 March 2006. Basingstoke, U. K.: Transplantation Society of Australia and New Zealand. doi: 10.1111/j.1440-1711.2006.01450.x

Effectiveness of a cardiovascular risk factor modification program in insulin-resistant renal transplant recipients

2006

Conference Publication

Use of dobutamine echocardiography for cardiovascular event prediction in chronic kidney disease: clinical scoring algorithms can optimize patients selection for testing

Rakhit, D., Armstrong, K. A., Johnson, D. W., Isbel, N. M. and Marwick, T. H. (2006). Use of dobutamine echocardiography for cardiovascular event prediction in chronic kidney disease: clinical scoring algorithms can optimize patients selection for testing. Japanese Society of Echocardiography, Tokyo, 27-28 April ,2006. UK: BMJ Publishing Group.

Use of dobutamine echocardiography for cardiovascular event prediction in chronic kidney disease: clinical scoring algorithms can optimize patients selection for testing

2005

Conference Publication

Does uric acid have a pathogenetic role in hypertension and kidney disease in renal transplant recipients?

Armstrong, K., Campbell, S., Johnson, D., Hawley, C. and Isbel, N. (2005). Does uric acid have a pathogenetic role in hypertension and kidney disease in renal transplant recipients?. 23rd Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand, Canberra, ACT, Australia, 11-13 May 2005. Oxford, United Kingdom: John Wiley & Sons.

Does uric acid have a pathogenetic role in hypertension and kidney disease in renal transplant recipients?

2005

Conference Publication

Body mass index predicts the progression of proteinuria in renal transplant recipients

Armstrong, K., Campbell, S., Hawley, C., Hiremagalur, B., Nicol, D., Johnson, D. and Isbel, N. (2005). Body mass index predicts the progression of proteinuria in renal transplant recipients. 23rd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New-Zealand, Canberra, ACT, Australia, 11-13 May 2005. Oxford, United Kingdom: John Wiley & Sons.

Body mass index predicts the progression of proteinuria in renal transplant recipients